Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the Nasal Cavity”

237 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 237 results

Testing effectiveness (Phase 2)UnknownNCT00003327
What this trial is testing

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Theradex 60
Testing effectiveness (Phase 2)Ended earlyNCT02196168
What this trial is testing

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+26 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Study completedNCT00524017
What this trial is testing

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)WithdrawnNCT00095641
What this trial is testing

S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more
SWOG Cancer Research Network
Early research (Phase 1)Study completedNCT00003430
What this trial is testing

L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Head and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00117572
What this trial is testing

Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

Who this might be right for
Cancer of the PharynxCancer of the LarynxCancer of the Nasal Cavity+2 more
University of Chicago 285
Not applicableStudy completedNCT00482872
What this trial is testing

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 400
Early research (Phase 1)Study completedNCT00083057
What this trial is testing

Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Study completedNCT00002888
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00978081
What this trial is testing

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Who this might be right for
Head and Neck CancerPrecancerous Condition
Abramson Cancer Center at Penn Medicine 35
Testing effectiveness (Phase 2)Study completedNCT00058006
What this trial is testing

Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00503997
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 42
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00509665
What this trial is testing

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Medical University of South Carolina 18
Not applicableStudy completedNCT01466257
What this trial is testing

Biomarkers in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 70
Testing effectiveness (Phase 2)UnknownNCT05114707
What this trial is testing

Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses

Who this might be right for
Nasal Cavity CancerParanasal Sinus CancerCamrelizumab+3 more
Sun Yat-sen University 57
Load More Results